XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Current assets:    
Cash and cash equivalents $ 11,585 $ 16,427
Accounts receivable and unbilled revenues, net 649 732
Contract asset 0 51
Prepaid expenses and other current assets 529 475
Receivable from patent assignment 19,389 0
Current assets of discontinued operations 41 0
Total current assets 32,193 17,685
Non-current assets:    
Property and equipment, net 160 62
Operating lease right-of-use assets, net 466 634
Total non-current assets 626 696
Total assets 32,819 18,381
Current liabilities:    
Accounts payable 525 229
Accrued payroll and employee benefits 909 760
Accrued expenses 248 404
Accrued broker fee from patent assignment 3,878 0
Contract liabilities 62 0
Current portion of finance lease obligations 12 2
Current portion of operating lease obligations 295 225
Total current liabilities 5,929 1,620
Non-current liabilities:    
Finance lease obligations, net of current portion 18 0
Operating lease obligations, net of current portion 69 319
Total non-current liabilities 87 319
Total liabilities 6,016 1,939
Commitments and contingencies (Note 4)
Stockholders’ equity:    
Preferred stock, 1,000,000 shares authorized, with par value of $0.001; no shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. 0 0
Common stock, 25,000,000 shares authorized, with par value of $0.001; 16,782,922 and 16,782,922 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively. 17 17
Additional paid-in capital 240,955 240,955
Accumulated other comprehensive loss (672) (450)
Accumulated deficit (213,497) (224,080)
Total stockholders’ equity 26,803 16,442
Total liabilities and stockholders’ equity $ 32,819 $ 18,381